These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

660 related items for PubMed ID: 19094812

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The DRESS syndrome: the great clinical mimicker.
    Fleming P, Marik PE.
    Pharmacotherapy; 2011 Mar; 31(3):332. PubMed ID: 21361742
    [Abstract] [Full Text] [Related]

  • 3. DRESS syndrome associated with carbamazepine and phenytoin.
    Allam JP, Paus T, Reichel C, Bieber T, Novak N.
    Eur J Dermatol; 2004 Mar; 14(5):339-42. PubMed ID: 15358574
    [Abstract] [Full Text] [Related]

  • 4. Sulphasalazine-induced DRESS.
    Teo L, Tan E.
    Singapore Med J; 2006 Mar; 47(3):237-9. PubMed ID: 16518561
    [Abstract] [Full Text] [Related]

  • 5. Drug rash with eosinophilia and systemic symptoms after chlorambucil treatment in chronic lymphocytic leukaemia.
    Vaida I, Roszkiewicz F, Gruson B, Makdassi R, Damaj G.
    Pharmacology; 2009 Mar; 83(3):148-9. PubMed ID: 19122478
    [Abstract] [Full Text] [Related]

  • 6. Life-threatening acute adverse cutaneous drug reactions.
    Wolf R, Orion E, Marcos B, Matz H.
    Clin Dermatol; 2005 Mar; 23(2):171-81. PubMed ID: 15802211
    [Abstract] [Full Text] [Related]

  • 7. Vancomycin-induced DRESS syndrome in a female patient.
    Vauthey L, Uçkay I, Abrassart S, Bernard L, Assal M, Ferry T, Djordjevic M, Roussos C, Vaudaux P.
    Pharmacology; 2008 Mar; 82(2):138-41. PubMed ID: 18607115
    [Abstract] [Full Text] [Related]

  • 8. [Drug patch tests in the investigation of cutaneous adverse drug reactions].
    Barbaud A.
    Ann Dermatol Venereol; 2009 Mar; 136(8-9):635-44. PubMed ID: 19686903
    [Abstract] [Full Text] [Related]

  • 9. Phenytoin-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a case report from the emergency department.
    Oelze LL, Pillow MT.
    J Emerg Med; 2013 Jan; 44(1):75-8. PubMed ID: 21852061
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The variable clinical picture of drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug.
    Kano Y, Shiohara T.
    Immunol Allergy Clin North Am; 2009 Aug; 29(3):481-501. PubMed ID: 19563993
    [Abstract] [Full Text] [Related]

  • 13. Drug reaction with eosinophilia and systemic symptoms: is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 cases.
    Walsh S, Diaz-Cano S, Higgins E, Morris-Jones R, Bashir S, Bernal W, Creamer D.
    Br J Dermatol; 2013 Feb; 168(2):391-401. PubMed ID: 23034060
    [Abstract] [Full Text] [Related]

  • 14. Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking.
    Walsh SA, Creamer D.
    Clin Exp Dermatol; 2011 Jan; 36(1):6-11. PubMed ID: 21143513
    [Abstract] [Full Text] [Related]

  • 15. Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update.
    Tas S, Simonart T.
    Dermatology; 2003 Jan; 206(4):353-6. PubMed ID: 12771485
    [Abstract] [Full Text] [Related]

  • 16. Carbamazepine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: report of four cases and brief review.
    Ganeva M, Gancheva T, Lazarova R, Troeva J, Baldaranov I, Vassilev I, Hristakieva E, Tzaneva V.
    Int J Dermatol; 2008 Aug; 47(8):853-60. PubMed ID: 18717872
    [Abstract] [Full Text] [Related]

  • 17. [The drug hypersensitivity syndrome or DRESS syndrome to phenobarbital].
    Lachgar T, Touil Y.
    Allerg Immunol (Paris); 2001 Apr; 33(4):173-5. PubMed ID: 11434197
    [Abstract] [Full Text] [Related]

  • 18. A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions.
    Barbaud A, Collet E, Milpied B, Assier H, Staumont D, Avenel-Audran M, Grange A, Amarger S, Girardin P, Guinnepain MT, Truchetet F, Lasek A, Waton J, Toxidermies group of the French Society of Dermatology.
    Br J Dermatol; 2013 Mar; 168(3):555-62. PubMed ID: 23136927
    [Abstract] [Full Text] [Related]

  • 19. Drug rash with eosinophilia and systemic symptoms induced by valproate and carbamazepine: formation of circulating auto-antibody against 190-kDa antigen.
    Yun SJ, Lee JB, Kim EJ, Quan G, Kim SJ, Won YH, Lee SC.
    Acta Derm Venereol; 2006 Mar; 86(3):241-4. PubMed ID: 16710584
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.